Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06379425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 10 months later Mar 1, 2026 → Jan 1, 2027
See other at-risk trials from Northwell Health

Record History

  1. Primary completion pushed from Mar 1, 2026 to Jan 1, 2027 Completion pushed from Mar 1, 2026 to Mar 1, 2027 · Eligibility criteria expanded, about 18 words Show 2 more changesShow less
    • Completion pushed from Mar 1, 2026 to Mar 1, 2027
    • Eligibility criteria expanded, about 18 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a double-arm randomized control trial evaluating the impact of preoperative opioid-free analgesia on time to trial of void in ambulatory urogynecologic surgeries. The investigators hypothesize that receipt of acetaminophen, celecoxib and gabapentin preoperatively versus acetaminophen alone will reduce the time to trial of void in patients undergoing same-day minor urogynecologic procedures.
Trial Details
NCT Number NCT06379425
Lead Sponsor Northwell Health
Conditions Pain, Postoperative, Postoperative Pain, Acute
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov